ClinicalTrials.Veeva

Menu

Processed Residual Pump Blood in Cardiac Surgery: The PRBC Trial

H

Hamilton Health Sciences (HHS)

Status

Completed

Conditions

Hemorrhage
Surgery
Cardiopulmonary Bypass

Treatments

Other: Ultrafiltration of residual blood

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The study is an randomized controlled trial (RCT) of 198 coronary artery bypass graft (CABG) patients, exploring whether ultrafiltration of residual blood in the cardiopulmonary bypass circuit reduces transfusion and bleeding.

Full description

Blood products are a limited resource and cardiac surgery is a high consumer. Processing residual cardiopulmonary bypass (CPB) volume via ultrafiltration may improve hemostasis and reduce transfusion through clearing activated complement, activated coagulation components, and proinflammatory cytokines. Unlike cell saver technology, ultrafiltration has the advantage of maintaining plasma proteins, platelets, and coagulation factors. We sought to establish if the processing of residual CPB volume with ultrafiltration reduces homologous blood transfusion and bleeding.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • at least 18 years of age
  • were to undergo isolated on-pump CABG
  • were able to give informed consent

Exclusion criteria

  • performed autologous blood donation
  • underwent off-pump CABG
  • emergency procedure
  • resternotomy
  • known bleeding disorder not drug related
  • history of heparin-induced thrombocytopenia
  • Jehovah's Witness
  • intra-operative catastrophe prior to randomization

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

200 participants in 2 patient groups

Treatment group
Experimental group
Description:
Ultra filtration of residual blood.
Treatment:
Other: Ultrafiltration of residual blood
Control
No Intervention group
Description:
The current practice in our institution was to displace all the remaining volume in the CPB circuit into a transfer pack by displacing the remaining blood in the CPB circuit with additional Lactated Ringers solution. This transfer pack is then given to the anesthetist for reinfusion into the patient.
Treatment:
Other: Ultrafiltration of residual blood

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems